Pyrazine-2-Carboxylic Acid Hydrazide → 7-[(2,4-Dichlorophenyl)carbonyl]-3-(2-pyrazinyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine
Reaction equation
[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[C:9]([N:11]1[CH2:16][CH2:15][NH:14][C:13](=O)[CH2:12]1)=[O:10].F[B-](F)(F)F.C([O+](CC)CC)C.[N:30]1[CH:35]=[CH:34][N:33]=[CH:32][C:31]=1[C:36]([NH:38][NH2:39])=O>ClCCl>[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[C:9]([N:11]1[CH2:16][CH2:15][N:14]2[C:36]([C:31]3[CH:32]=[N:33][CH:34]=[CH:35][N:30]=3)=[N:38][N:39]=[C:13]2[CH2:12]1)=[O:10]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of 4-[(2,4-dichlorophenyl)carbonyl]-2-piperazinone (I6) (0.273 g, 1 mmol) in dry Dichloromethane (DCM) (3 ml) was stirred at room temperature under argon. Triethyloxonium tetrafluoroborate (0.199 g, 1.050 mmol) was added and the reaction solution was stirred for 10 minutes. 2-pyrazinecarbohydrazide (0.166 g, 1.200 mmol, commercially available) was then added and the solution was stirred for a further 1 hour. The solvent was then concentrated before n-butanol (3.00 ml) was added and the solution was stirred, under reflux and argon, for 4 hours. LCMS confirmed product location, thus the solution was cooled to room temperature before the solvent was evaporated in vacuo. The remaining residue was then purified by flash chromatograpghy (Biotage SP4, 25M cartridge) with a gradient of 0 to 10% 2M NH3/MeOH in DCM. TLC confirmed product location and the solvent from the combined fractions was evaporated in vacuo. The remaining residue was then further purified by mass-directed automated HPLC. The solvent was then evaporated in vacuo, and the remaining solid was triturated with ether, and dried in a vacuum oven to yield the product in 0.137 g.
Workup
- stirringthe solution was stirred for a further 1 hour
- concentrationThe solvent was then concentrated before n-butanol (3.00 ml)
- additionwas added
- stirringthe solution was stirred
- temperatureunder reflux
- waitargon, for 4 hours
- customwas evaporated in vacuo
- customThe remaining residue was then purified by flash chromatograpghy (Biotage SP4, 25M cartridge) with a gradient of 0 to 10% 2M NH3/MeOH in DCM
- customthe solvent from the combined fractions was evaporated in vacuo
- customThe remaining residue was then further purified
- customThe solvent was then evaporated in vacuo
- customthe remaining solid was triturated with ether
- customdried in a vacuum oven
- customto yield the product in 0.137 g
Sources & evidence
- ORD record
- ord-25c4e5021d5a4953916ab1a7ec753df5
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08501946B2
Reaction notes
Loading…